These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23399877)

  • 21. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.
    Umhau JC; Schwandt ML; Usala J; Geyer C; Singley E; George DT; Heilig M
    Neuropsychopharmacology; 2011 May; 36(6):1178-86. PubMed ID: 21289601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acamprosate reduces ethanol intake in the rat by a combined action of different drug components.
    Ademar K; Loftén A; Nilsson M; Domi A; Adermark L; Söderpalm B; Ericson M
    Sci Rep; 2023 Oct; 13(1):17863. PubMed ID: 37857829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acamprosate. Pharmacoeconomic implications of therapy.
    Foster RH; McClellan KJ
    Pharmacoeconomics; 1999 Dec; 16(6):743-55. PubMed ID: 10724798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.
    De Witte P; Littleton J; Parot P; Koob G
    CNS Drugs; 2005; 19(6):517-37. PubMed ID: 15963001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acamprosate for alcohol dependence.
    Rösner S; Hackl-Herrwerth A; Leucht S; Lehert P; Vecchi S; Soyka M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004332. PubMed ID: 20824837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
    Scott LJ; Figgitt DP; Keam SJ; Waugh J
    CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acamprosate: A Review of Its Use in Alcohol Dependence.
    Plosker GL
    Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
    Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
    Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of acamprosate: an overview.
    Zornoza T; Cano MJ; Polache A; Granero L
    CNS Drug Rev; 2003; 9(4):359-74. PubMed ID: 14647529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deterrent Action of Acamprosate: A Case Report.
    Spoorthy MS; Godi S; Singh LK
    Addict Health; 2019 Oct; 11(4):276-280. PubMed ID: 32206220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acamprosate.
    Kennedy WK; Leloux M; Kutscher EC; Price PL; Morstad AE; Carnahan RM
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):363-80. PubMed ID: 20163323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acamprosate in alcohol dependence: how does it work?
    Littleton J
    Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
    Mason BJ; Crean R
    Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence.
    Ralevski E; O'Brien E; Jane JS; Dwan R; Dean E; Edens E; Arnaout B; Keegan K; Drew S; Petrakis I
    J Dual Diagn; 2011; 7(1-2):64-73. PubMed ID: 26954912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
    Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
    Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence.
    Kiefer F; Andersohn F; Otte C; Wolf K; Jahn H; Wiedemann K
    Acta Neuropsychiatr; 2004 Oct; 16(5):233-8. PubMed ID: 26984435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.